more_reports

The Latest Cannabis Articles from Streetwise Reports

Record Profits, a Vape Market Landgrab, and a CA$250M Facility Bought for CA$27M

Research Report
  ()
Atrium Research initiated coverage on Cannara Biotech Inc. (LOVE:TSX; LOVFF:OTCQX; BCB0:FSE), citing the company's dominant position in Quebec's new vape category, best-in-class EBITDA margins of 29%, and a capital-efficient expansion path at its Valleyfield facility that could unlock 100,000 kg of annual production capacity by FY30.
Tags: CannabisBiotechnology / Pharmaceuticals

Showing Results: 1 to 1 of 1